Technical Analysis for ORPH - Open Orphan plc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | -1.75% | |
| 50 DMA Resistance | Bearish | -1.75% | |
| Wide Bands | Range Expansion | -1.75% | |
| 20 DMA Resistance | Bearish | -1.75% | |
| 50 DMA Resistance | Bearish | -1.75% | |
| Shooting Star Candlestick | Bearish | -1.75% | |
| Lizard Bearish | Bearish Day Trade Setup | -1.75% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -1.75% | |
| Doji - Bearish? | Reversal | -1.75% | |
| Wide Bands | Range Expansion | -1.75% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 3x Volume Pace | about 2 hours ago |
| 2x Volume Pace | about 2 hours ago |
| 1.5x Volume Pace | about 2 hours ago |
| 10 DMA Support | about 3 hours ago |
| Fell Below Previous Day's Low | about 4 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Open Orphan plc operates as a clinical research organization pharmaceutical services company with a focus on virology, vaccine studies, and orphan drugs in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. It operates a virtual rep, a pharmaceutical commercialization platform for rare/orphan disease space; and develops Genomic Health Data platform, a collection of infectious disease progression data. The company also provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations. In addition, it offers hVIVO COVID Clear Test, an antibody test for employers in the United Kingdom and Ireland. The company is headquartered in London, the United Kingdom.
Keywords: Health Biotechnology Life Sciences Clinical Trial Pharmaceutical Industry Drug Discovery Health Sciences Clinical Research Infectious Disease Vaccine Design Of Experiments Pharmaceuticals Policy Food And Drug Administration Clinical Trial Services
Classification
Keywords: Health Biotechnology Life Sciences Clinical Trial Pharmaceutical Industry Drug Discovery Health Sciences Clinical Research Infectious Disease Vaccine Design Of Experiments Pharmaceuticals Policy Food And Drug Administration Clinical Trial Services
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 40.0 |
| 52 Week Low | 10.55 |
| Average Volume | 1,798,648 |
| 200-Day Moving Average | 19.36 |
| 50-Day Moving Average | 14.73 |
| 20-Day Moving Average | 14.72 |
| 10-Day Moving Average | 13.69 |
| Average True Range | 1.19 |
| RSI | 46.81 |
| ADX | 19.6 |
| +DI | 18.56 |
| -DI | 18.94 |
| Chandelier Exit (Long, 3 ATRs) | 14.44 |
| Chandelier Exit (Short, 3 ATRs) | 15.38 |
| Upper Bollinger Bands | 17.20 |
| Lower Bollinger Band | 12.24 |
| Percent B (%b) | 0.41 |
| BandWidth | 33.72 |
| MACD Line | -0.43 |
| MACD Signal Line | -0.40 |
| MACD Histogram | -0.0252 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 15.75 | ||||
| Resistance 3 (R3) | 15.83 | 15.42 | 15.50 | ||
| Resistance 2 (R2) | 15.42 | 15.03 | 15.38 | 15.42 | |
| Resistance 1 (R1) | 14.83 | 14.80 | 14.63 | 14.75 | 15.33 |
| Pivot Point | 14.42 | 14.42 | 14.31 | 14.38 | 14.42 |
| Support 1 (S1) | 13.83 | 14.03 | 13.63 | 13.75 | 13.17 |
| Support 2 (S2) | 13.42 | 13.80 | 13.38 | 13.08 | |
| Support 3 (S3) | 12.83 | 13.42 | 13.00 | ||
| Support 4 (S4) | 12.75 |
